vTv Therapeutics Inc. (VTVT) Fundamentals

vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Its major drug candidate to treat Alzheimer's is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders.
SHARE INFORMATION
Market Cap$ 80,424,313
Shares Outstanding81,483,600
Float44,873,288
Percent Float55.07%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 4,005,000
Latest Fiscal EPS$ -0.22
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions53
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months23,396
Institutional Holdings Percent7.6%
Institutional Sold Previous 3 Months288,308
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months622,000
Insider Holdings Percent0.3
Insider Sold Previous 3 Months-
Insider Shares Owned280,113
TRADING INFO
52 Week High$ 1.40
52 Week Low$ 0.38
52 Week High Change$ 28.43
21 Day Moving Average$ 0.8172
21 Day Extended Moving Average$ 0.865024
50 Day Moving Average$ 0.8017
50 Day Extended Moving Average$ 0.83435
200 Day Moving Average$ 0.827649
200 Day Extended Moving Average$ 0.90357
10 Day Average Volume88,752
20 Day Average Volume93,320
30 Day Average Volume87,507
50 Day Average Volume72,202
Alpha0.017778
Beta-1.1110
Standard Deviation0.385020
R20.024211
7 Day Price Change$ 0.077
7 Day Percent Change8.46%
21 Day Price Change$ 0.2172
21 Day Percent Change28.22%
30 Day Price Change$ 0.3084
30 Day Percent Change45.45%
Month to Date Price Change$ 0.3242
Month to Date Percent Change48.91%
Quarter to Date Price Change$ 0.3242
Quarter to Date Percent Change48.91%
180 Day Price Change$ 0.2325
180 Day Percent Change30.82%
200 Day Price Change$ 0.3321
200 Day Percent Change50.71%
Year to Date Price Change$ 0.3242
Year to Date Percent Change48.91%

vTv Therapeutics Inc. (VTVT) Key Ratios

PROFITABILITY
EBIT Margin-1,400.0%
EBITDA Margin-1,395.4%
Pre-Tax Profit Margin-25,010.1%
Profit Margin Count-78.87%
Gross Margin0.0%
Profit Margin TOT-78.87%
INCOME STATEMENTS
Revenue$ 2,009,000
Revenue Per Share$ 0.0247
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-4.80
Total Debt To Equity0.00
Int Coverage-1,883.40
Current Ratio3.90
Leverage Ratio-2.80
Quick Ratio3.70
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-3.30
Enterprise Value$ 66,020,346
Price to Sales40.032
Price to Free Cash-8.80
PE High Last 5 Years-4.70
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years-5.00
Price to Tangible Book-4.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.30
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-69.10
Return on Equity123.32
Return on Capital0.00

vTv Therapeutics Inc. (VTVT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOPaul Sekhri
Emplyoees9
Last AuditUE
CIK0001641489
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address3980 Premier Drive
Suite 310
High Point, NC 27265
Websitehttps://www.vtvtherapeutics.com
Facsimile+1 336 841-0310
Telephone+1 336 841-0300
EmailIR@vtvtherapeutics.com


Your Recent History
NASDAQ
VTVT
vTv Therap..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.